The expression of functionally-coupled B2-bradykinin receptors in human corneal epithelial cells and their pharmacological characterization with agonists and antagonists

British Journal of Pharmacology

Volumn 121, Issue 4, 1997, Pages 649-656

  Wiernas, T K ^a,b   Griffin, B W ^a,b   Sharif, N A ^a,b  

^a ALCON RESEARCH LTD   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Bradykinin; Bradykinin receptors; Conjunctivitis; Cornea; Corneal epithelium; Hoe 140; Inflammation

Indexed keywords

BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR AGONIST; BRADYKININ B2 RECEPTOR ANTAGONIST; HISTAMINE; ICATIBANT; INOSITOL PHOSPHATE; PHOSPHATIDYLINOSITIDE; RECEPTOR SUBTYPE; THROMBOCYTE ACTIVATING FACTOR;

ALLERGY; ARTICLE; BIOASSAY; CELL CULTURE; CELL STIMULATION; CELL TRANSFORMATION; CONTROLLED STUDY; CORNEA EPITHELIUM; DRUG POTENCY; EPITHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SIMIAN VIRUS 40; TEAR FILM; WOUND HEALING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRADYKININ; CELL CULTURE TECHNIQUES; CORNEA; ENDOTHELIUM, CORNEAL; HUMANS; INOSITOL PHOSPHATES; RECEPTORS, BRADYKININ;

EID: 0030912960     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701168     Document Type: Article

References (61)

1. ABELSON, M.B. & SCHAEFER, K. (1993). Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy. Survey Ophthalmol., 38, 115-132.
2. ABDEL-LATIF, A.A. (1995). Phosphosinositide and arachidonic acid signalling systems in the mammalian iris. Prog. Retinal Eye Res., 14, 75-107.
3. ALLANSMITH, M.R. & ROSS, R.N. (1988). Ocular Allergy. Clin. Allergy, 18, 1-13.
4. ARAKI-SASAKI, K., OHSAKI, Y., SASABE, T., HAYASHI, K., WATANABE, H., TANO, Y. & HANDA, H. (1995). An SV40-immortalized human corneal epithelial cell line and its characterization. Invest. Ophthalmol. Vis. Sci., 36, 614-621.
5. ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother., 14, 48-58.
6. BAZAN, H.E.P., TAO, Y. & HURST, J.S. (1994). Platelet-activating factor antagonists and ocular inflammation. J. Ocular Pharmacol., 10, 319-327.
7. BEDARD, M., MACCLURE, C.D., SCHILLER, N.L., FRANCOEUR, C., CANTIN, A. & DENIS, M. (1993). Release of interleukin-8, interleukin-6 and colony stimulating factors by upper airway epithelial cells: implication for cystic fibrosis. Am. J. Cell. Mol. Biol., 9, 455-462.
8. BENEZRA, D., HEMO, I. & MAFTZIR, G. (1990). In vivo angiogenic activity of interleukins. Arch. Ophthalmol., 108, 573-576.
9. BERRIDGE, M.J., DOWNES, C.P. & HANLEY, M.R. (1982). Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary gland. Biochem. J., 206, 587-595.
10. BERRIDGE, M.J. & IRVINE, R.F. (1984). Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature, 312, 315-321.
11. BEUERMEN, R.W., CROSSON, C.E. & KAUFMAN, H.E. (ed.) (1989). Heating Processes in The Cornea: Advances in Applied Biotechnology Series, Vol. 1, London: Gulf Publishing Company.
12. 1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction and phosphatidylinositol hydrolysis. Br. J. Pharmacol., 114, 612-617.
13. BYNKE, G., HAKANSON, R., HORIG, J. & LEANDER, S. (1983). Bradykinin contracts the pupillary sphincter and evokes ocular inflammation through release of neuronal substance P. Eur. J. Pharmacol, 91, 469-475.
14. 50) of an enzymatic reaction. Biochem. Pharmacol., 22, 3099-3108.
15. COLE, D.F. (1974). The site of breakdown of the blood-aqueous barrier under the influence of vasodilator drugs. Exp. Eye Res., 19, 591-607.
16. COLE, D.F. & UNGAR, W.G. (1974). Action of bradykinin on intraocular pressure and pupillary diameter. Ophthalmol. Res., 6, 308-314.
17. CUBITT, C.L., TANG, Q., MONTERIO, C.A., LAUSCH, R.N. & OAKES, J.E. (1993). IL-3 gene expression in cultures of human corneal epithelial cells and keratocytes. Invest. Ophthalmol. Vis. Sci., 34, 3199-3206.
18. DRAY, A. & PERKINS, M. (1993). Bradykinin and inflammatory pain. Trends Neurosci., 16, 99-104.
19. ELLIOTT, P.J., MACKIC, J.B., GRANEY, W.F., BARTUS, R.T. & ZLOKOVIC, B.V. (1995). RMP-7, bradykinin agonist, increases permeability of blood-ocular barriers in the guinea pig. Inves. Ophthal. Vis. Sci., 36, 2542-2547.
20. FARMER, S.G. & BURCH, R.M. (1992). Biochemical and molecular pharmacology of kinin receptors. Ann. Rev. Pharmacol. Toxicol., 32, 511-536.
21. FIGINI, M., JAVDAN, P., CIONCOLINI, F. & GEPPETTI, P. (1995). Involvement of tachykinins in plasma extravasation induced by bradykinin and low pH medium in the guinea pig conjunctiva. Br. J. Pharmacol., 115, 128-132.
22. GAO, X., STEWART, J.M., VAVREK, R.J. & GREENBAUM, L.M. (1993). Characterization of receptor-mediated actions of T-kinin. Biochem. Pharmacol., 46, 1607-1612.
23. HALL, J.M. (1992). Bradykinin receptors: pharmacological properties and biological roles. Pharmacol. Ther., 56, 131-190.
24. 2 receptor antagonist WIN-64338 in vivo and in vitro. Br. J. Pharmacol., 116, 3164-3168.
25. HOCK, F.J., WIRTH, K., ALBUS, U., LINZ, W., GERHARDS, H.J., WIEMER, G., ST. HENKE, G., BREIPOHL, G., KONIG, W., KNOLLE, J. & SCHOLKEN, B.A. (1991). Hoe-140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol., 102, 769-773.
26. KAHN, C.R., YOUNG, E., LEE, I.H. & REHM, J.S. (1993). Human corneal epithelial primary cultures and cell lines with extended life span: in vitro model for ocular studies. Invest. Ophthalmol. Vis. Sci., 34, 3429-3441.
27. MA, J-X., SONG, Q., HATCHER, H.C., CROUCH, R.K., CHAO, L. & CHAO, J. (1996). Expression and cellular localization of the kallikrein-kinin system in human ocular tissues. Exp. Eye. Res., 63, 19-26.
28. 1 receptors: A review. Immunopharmacology, 30, 1-26.
29. 2 receptors on the venoconstrictor action of bradykinin. J. Pharmacol. Exp. Ther., 269, 1136-1143.
30. MARCEAU, F., LUSSIER, A., REGOLI, D. & GIROUD, J.P. (1993). Pharmacology of kinins: their relevance to tissue injury and inflammation. Gen. Pharmacol., 14, 209-229.
31. MCGEE, D.W., BEAGLEY, K.W., AICHER, W.K. & MCGHEE, J.R. (1992). Transforming growth factor-α enhances interleukin-6 secretion by intestinal epithelial cells. Immunology, 77, 7-12.
32. MICHEL, A.D. & WHITING, R.L. (1984). Analysis of ligand binding data using a microcomputer. Br. J. Pharmacol., 83, 460P.
33. OFFORD, E.A., TROMVOUKIS, Y., HOWE, W.E., SHARIF, N.A. & PFEIFER, A.M.A. (1997). Establishment of an SV-40 immortalized human corneal epithelial cell-line with cytokeratin, cytokine, growth and metabolic enzyme expression similar to corneal epithelium. Exp. Eye Res., (in press).
34. PAEGELOW, I., WERNER, H., VIETINGHOFF, G. & WARTNER, U. (1995). Release of cytokines from isolated lung strips by bradykinin. Inflamm. Res., 44, 306-311.
35. PFEIFER, A.M.A., COLE, K.E., SMOOT, D.T., WESTON, A., GROOPMAN, J.D., SHIELDS, P.G., VIGNAUD, J-M., JUILLERAT, M., LIPSKY, M.M., TRUMP, B.F., LECHNER, J.F. & HARRIS, C.C. (1993). Simian virus 40 large tumour antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens. Proc. Natl. Acad. Sci. U.S.A., 90, 5123-5127.
36. PHAGOO, S.B., YAQOOB, M., BROWN, M.C.S. & BURGESS, G.M. (1996). Selective labelling of bradykinin receptor subtypes in W138 human lung fibroblasts. Br. J. Pharmacol., 119, 863-868.
37. PROIA, A.D. (1994). Inflammation. In Pathobiology of Ocular Disease, ed Garner, A. & Klintworth, G.K., Chapter 2, pp. 63-99. New York: Marcel Dekker.
38. PROUD, D., SWEET, J., STEIN, P., SETTIPANE, R.A., KAGEYSOBOTKA, A., FREIDLAENDER, M.H. & LICHTENSTEIN, L.M. (1990). Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen. J. Allergy Clin. Immunol., 85, 896-905.
39. 2-bradykinin receptor on a subclone of PC-12 cells. J. Neurochem., 56, 983-989.
40. REGOLI, D. & BARABEI, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol. Rev., 32, 1-46.
41. 2 receptor characterization. Trends Pharmacol. Sci., 11, 156-161.
42. ROSENBAUM, J.T., PLANCK, S.R., HUANG, X-N., RIC, L. & ANSEL, J.C. (1995). Detection of mRNA for the cytokines, interleukin-1a, and interleukin-8, in corneas from patients with pseudophakic bullous keratopathy. Invest. Opthalmol. Vis. Sci., 36, 2151-2155.
43. SAHA, J.K., SENGUPTA, J.N. & GOPAL, R.K. (1990). Effect of bradykinin on opposum oesophgeal longitudinal smooth muscle: evidence for novel bradykinin receptors. J. Pharmacol. Exp. Ther., 252, 1012-1020.
44. SAUDER, D.N. (1990). The role of epidermal cytokines in inflammatory skin diseases. J. Invest. Dermatol., 95, 27S-28S.
45. SHARIF, N.A., CRIDER, J.Y., GRIFFIN, B.W., DAVIS, T.L. & HOWE, W.E. (1997a). Pharmacological analysis of mast cell mediator receptors coupled to adenylate cyclase and phospholipase C on immunocytochemically-defined human conjunctival epithelial cells. J. Ocular Pharmacol. Ther., (in press).
46. 2-receptor. Neurosci. Lett., 86, 279-283.
47. SHARIF, N.A., OFFORD, E.A., TROMVOUKIS, Y., HOWE, W.E., GRIFFIN, B.W., WIERNAS, T.K. & PFEIFER, A.M.A. (1997b). Immortalized human corneal epithelial (CEPI) cell for use in ocular inflammation and toxicity studies. Assoc. Res. Vision Opthalmol., Abst. #1090.
48. 2-bradykinin receptors in guinea pig brain regions, spinal cord and peripheral tissues. Neurochem. Int., 18, 89-96.
49. 2-antagonist-sensitive responses and receptor binding studies. Neurochem. Res., 12, 1313-1320.
50. SHARIF, N.A., WIERNAS, T.K., GRIFFIN, B.W., HOWE, W.E., OFFORD, E.A. & PFEIFER, A.M.A. (1997c). Similarity of the biochemical pharmacology of phospholipase C-coupled receptors for histamine, brakykinin and platelet-activating factor on immunocytochemically-defined primary and SV40-immortalized human corneal epithelial cells. Exp. Eye Res., (in press).
51. SHARIF, N.A. & XU, S.X. (1996). Pharmacological characterization of bradykinin receptors coupled to phosphoinositide turnover in SV40-immortalized human trabecular meshwork cells. Exp. Eye Res., 63, 631-637.
52. 1-selective antagonist for ocular use. Receptor binding and second messenger studies. J. Ocular Pharmacol., 10, 653-664.
53. SHARIF, N.A., XU, S.X., MILLER, S.T., GAMACHE, D.A. & YANNI, J.M. (1996). Characterization of the ocular anti-allergic and anti-histaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases. J. Pharmacol. Exp. Ther., 278, 1251-1260.
54. SHARMA, J.N. (1993). Therapeutic prospects of bradykinin receptor antagonists. Gen. Pharmacol., 24, 267-274.
55. 2 bradykinin receptors in bovine pulmonary artery endothelial cells. Mol. Pharmacol., 47, 525-534.
56. TIEN, X-Y., WALLACE, L.J., KACHUR, J.F., WON-KIM, S. & GAGINELLA, T.S. (1990). Characterization of Ile-Ser-bradykinin-induced changes in short circuit current across rat colon. J. Pharmacol. Exp. Ther., 254, 1063-1067.
57. 9-bradykinin and bradykinin. J. Pharmacol. Exp. Ther., 264, 930-937.
58. WAHLESTEDT, C., BYNKE, G. & HAKANSON, R. (1985). Pupillary constriction by bradykinin and capsaicin: mode of action. Eur. J. Pharmacol., 106, 577-583.
59. WATANABE, H., FABRICANT, M., TISDALE, A.S., SPURRMICHAUD, S.J., LINDBERG, K. & GIPSON, I.L. (1995). Human corneal and conjunctival epithelia produce a mucin-like glycoprotein for the apical surface. Invest. Ophthalmol. Vis. Sci., 36, 337-344.
60. 2 kinin receptors in cultured bovine aortic endothelial cells. J. Pharmacol. Exp. Ther., 262, 729-733.
61. WIRTH, K.J., HEITSCH, H. & SCHOLKENS, B.A. (1995). Kinin receptor antagonists: unique probes in basic and clinical research. Can. J. Physiol. Pharmacol., 73, 797-804.